New Drugs

Brand/Generic Company Description
Aimovig
erenumab-aooe
Click here for more information
Amgen

A calcitonin gene-related peptide receptor antagonist to prevent migraine.

Akynzeo
fosnetupitant/palonosetron
Click here for more information
Helsinn

An injectable formulation for prevention of chemo-induced nausea and vomiting.

Andexxa
coagulation factor Xa
Portola Pharm

Anticoagulation reversal agent for rivaroxaban and apixaban.

Biktarvy
bictegravir/ emtricitabine/tenofovir alafenamide
Click here for more information
Gilead Sciences

A combination drug for treatment of HIV-1 infection.

Braftovi
encorafenib
Click here for more information
Array BioPharma

A kinase inhibitor for metastatic melanoma.

Crysvita
burosumab-twza
Click here for more information
Ultragenyx

A fibroblast growth factor 23 blocking antibody for X-linked hypophosphatemia.

Doptelet
avatrombopag
Click here for more information
Dova Pharm.

A thrombopoietin receptor agonist for thrombocytopenia in patients with chronic liver disease prior to undergoing a procedure.

Epidiolex
cannabidiol
Click here for more information
Greenwich Biosciences

A CBD oral solution for seizures associated with Lennox-Gastaut syndrome or Dravet syndrome.

Erleada
apalutamide
Click here for more information
Janssen

An androgen receptor inhibitor for non-metastatic, castration-resistant prostate cancer.

Fulphila
pegfilgrastim-jmdb
Click here for more information
Mylan

The first biosimilar to Neulasta.

Ilumya
tildrakizumab-asmn
Click here for more information
Merck

An interleukin-23 antagonist for moderate-to-severe plaque psoriasis.

Lokelma
sodium zirconium cyclosilicate
Click here for more information
AstraZeneca

A potassium binder for hyperkalemia.

Lucemyra
lofexidine
Click here for more information
US WorldMeds

An alpha-2 agonist to reduce opioid withdrawal symptoms.

Lutathera
lutetium Lu 177 dotatate
Click here for more information
Advanced Accelerator Applic.

A radiopharmaceutical for gastroenteropancreatic neuroendocrine tumors.

Mektovi
binimetinib
Click here for more information
Array BioPharma

A kinase inhibitor for metastatic melanoma.

Moxidectin
moxidectin
Click here for more information
Medicines Devlopment

An anthelmintic for onchocerciasis.

Olumiant
baricitinib
Click here for more information
Lilly

An oral Janus kinase inhibitor for rheumatoid arthritis.

Palynziq
pegvaliase-pqpz
Click here for more information
BioMarin Pharm.

An enzyme to reduce blood phenylalanine levels in patients with phenylketonuria.

Retacrit
epoetin alfa-epbx
Click here for more information
Hospira

A biosimilar to Epogen/Procrit.

Symdeko
tezacaftor/ivacaftor
Click here for more information
Vertex Pharm.

A combination formulation for cystic fibrosis in patients with a specific gene mutation.

Tavalisse
fostamatinib
Click here for more information
Rigel Pharm.

A kinase inhibitor for chronic immune thrombocytopenia.

Trogarzo
ibalizumab-uiyk
Click here for more information
Thera Technologies

An antiretroviral for patients with multidrug resistant HIV-1 infection.

Zemdri
plazomicin
Click here for more information
Achaogen

An aminoglycoside antibiotic for complicated UTI including pyelonephritis.

Brand/Generic Company Description
Apadaz
benzhydrocodone/acetaminophen
Click here for more information
KemPharm

New combination formulation for short-term management of acute pain.

Cimduo
lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection.

Consensi
amlodipine/celecoxib
Click here for more information
Kitov Pharma

New CCB/NSAID combination formulation for patients with hypertension and osteoarthritis.

Dexycu
dexamethasone
Click here for more information
Icon Bioscience

New intraocular suspension formulation for postoperative inflammation.

Firvanq
vancomycin
CurtisPharma

An oral solution formulation for C. difficile-associated diarrhea and enterocolitis caused by S. aureus (including MRSA).

Imvexxy
estradiol
Click here for more information
TherapeuticsMD

New vaginal insert estrogen formulation for dyspareunia due to menopause.

Jynarque
tolvaptan
Otsuka America

New formulation of tolvaptan to slow kidney function decline in patients at risk of progressing autosomal dominant polycystic kidney disease.

Nocdurna
desmopressin
Click here for more information
Ferring

New sublingual tablet formulation for nocturia.

Osmolex ER
amantadine
Click here for more information
Vertical Pharm.

New extended-release tablet formulation.

Plenvu
PEG 3350 plus electrolytes
Click here for more information
Norgine

A lower-volume, 1-liter bowel prep for colonoscopies.

Qbrexza
glycopyrronium
Dermira

An anticholinergic topical treatment for axillary hyperhidrosis.

Symfi
efavirenz/lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection. Contains a higher strength of efavirenz/tablet vs Symfi Lo.

Symfi Lo
efavirenz/lamivudine/tenofovir disoproxil fumarate
Click here for more information
Mylan

New combination formulation for HIV-1 infection.

Yonsa
abiraterone
Click here for more information
Sun Pharm.

New lower strength formulation for metastatic castration-resistant prostate cancer.

Ztlido
lidocaine
Click here for more information
Scilex Pharm.

New topical patch formulation for post-herpetic neuralgia pain.

Brand/Generic Company Description
Zinbryta
Daclizumab
Click here for more information
Biogen/AbbVie

The manufacturer is removing the drug from the worldwide market due to safety concerns, including reports of severe liver damage and immune-related conditions.